Approvals/TGA/ARIXTRA fondaparinux sodium 10mg/0.8mL solution for injection syringe

Approved

STANDARD

ARIXTRA fondaparinux sodium 10mg/0.8mL solution for injection syringe

Aspen Pharmacare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b6068ed1c2f938a4
Product Name: ARIXTRA fondaparinux sodium 10mg/0.8mL solution for injection syringe
Artg Id: 97800
Artg Name: ARIXTRA fondaparinux sodium 10.0mg/0.8mL solution for injection syringe
Sponsor: Aspen Pharmacare Australia Pty Ltd
Company Detail Path: /organization/aspen-pharmacare-australia-pty-ltd
Artg Date: 2004-11-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-02298-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b6068ed1c2f938a4

Type

Standard